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 Management of diabetic ketoacidosis – effect of a quality 
improvement programme and its long-term follow-up 
 Aims 
 To study the effect of a quality improvement programme 
(QIP) on the overall care for patients admitted with diabetic 
ketoacidosis (DKA). 
 Methods 
 Patients aged ≥17 years admitted with DKA from April 2014 
to September 2016 at a large teaching hospital in the West 
Midlands were included in the study. Patients managed in 
intensive care units were excluded to avoid bias from one-to-
one care. Various interventions were introduced from October 
2014 to March 2015 to improve DKA care as part of the QIP. 
The study period was divided into five groups of 6 months: 
baseline (52), intervention (52), early (53), intermediate 
(66) and late- (36) follow-up period. Data measuring socio-
demographic profile (age, gender, ethnicity) and various 
aspects of DKA management (presenting aetiology, glucose 
and ketone monitoring, prescribing fixed-rate insulin infusion 
and fluids) were collected and analysed using Microsoft Excel 
(version 2010) Statistical Analysis Software Package version 
23 (IBM Corp., USA). The primary outcome of the study was 
measured by the effect on DKA duration. Results are expressed 
in percentage and median with interquartile range (IQR) as 
appropriate. 
 Results 
 A total of 259 DKA episodes (male:female, 1:1.14) were 
analysed. There was no significant difference in the age 
between the groups. Poor compliance (32.1%) was the most 
common precipitating factor of DKA during the study. Glucose 
was monitored hourly in 91.7% (IQR, 83.3–108.2%) in pre-
intervention, 91.7% (IQR, 75.0–114.6%) in intervention, 116.7% 
(IQR, 91.7–150.5%) of early, 125.2% (IQR, 100.1–149.1%) in 
intermediate and 120.3% (IQR, 91.4–143.9%) in late follow-
up groups respectively. Hourly ketone monitoring was met in 
58.3% (IQR, 25.0–80.6%) in pre-intervention, 50.0% (IQR, 
33.3–73.0%) in intervention, 42.2% (IQR, 26.2–66.9%) in early, 
61.3% (IQR, 41.2–83.8%) in intermediate and 51.5% (IQR, 
26.3–71.4%) in late follow-up patients respectively. 
 The duration of DKA during the five groups as defined above 
were 20.5 hours (IQR, 12.5–41.1 hours), 16.6 hours (IQR, 
11.9–27.9 hours), 11.5 hours (IQR, 7.1–20.7 hours), 7.4 hours 
(IQR, 5.0–11.3 hours) and 9.0 hours (IQR, 6.8– 15.6 hours) 
respectively. Overall, there was statistically significant reduction 
in DKA duration following intervention, and the effect of QIP 
persisted up to 1 year post-intervention. 
 Conclusions 
 A well-designed QIP based on specific targets and continued 
feedback improved the quality of care for DKA. Although there 
was a significant reduction in DKA duration through our QIP, 
an increasing DKA duration trend during long-term follow-up 
suggests the need for ongoing interventions to maintain the 
improvements. ■ 
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